摘要
目的:了解耐多药鲍曼不动杆菌检出患者的临床特点,寻找对这一高度耐药菌所致感染患者进行药学监护的方法和对策,为临床合理应用抗菌药物提供依据。方法:对2012年1月—2012年5月检出耐多药鲍曼不动杆菌的住院患者进行基本信息的记录、临床观察和药学监护。结果:进行监护的68例患者中,10例检出耐多药鲍曼不动杆菌,8例接受抗菌药物治疗,死亡7例,1例显效。结论:耐多药鲍曼不动杆菌感染的诊断、预防控制上存在诸多问题,临床缺乏有效的抗感染治疗方法。
OBJECTIVE ：To investigate the clinical features of patients with positive detection of multidrug acinetobacter baumannii, and explore the approaches to pharmaceutical care and the countermeasures for resistant patientsinfected with this kind of highly resistant bacteria so as to provide reference for clinical rational use of antibiotics. METHODS： The patients with positive detection of multidrug resistant acinetobacter baumannii during January-May period of 2012 were given record of basic information, clinical observation and pharmaceutical care. RESULTS ： Of the total 68 cases that received pharmaceutical care, multidrug resistant acinetobacter baumannii were detected in l0 cases; antibiotic therapy was given in 8 cases; 7 patients died and 1 showed excellent efficacy. CONCLUSION： There are many problems lie in the diagnosis, prevention and control of the muhidrug resistant acinetobacter baumanniis infection and there is as yet lack of effective anti-infective therapy clinically.
出处
《中国医院用药评价与分析》
2013年第11期1042-1045,共4页
Evaluation and Analysis of Drug-use in Hospitals of China
关键词
耐多药鲍曼不动杆菌
抗感染治疗
药学监护
Multi-drug resistant acinetobacter baumannii
Anti-infective therapy
Pharmaceutical care
